CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ: LIFE) announced today that it has given notice of its intention to redeem all of the outstanding 3.25% Convertible Senior Notes due 2025 (the “2025 Convertible Notes”) on June 15, 2011. As of May 6, 2011 there was $350,000,000 in aggregate principal amount of the 2025 Convertible Notes […]
BERLIN and BURLINGTON, Mass. – caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry (CCMS) platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million ($1.4 M) to its Series B financing, increasing total equity for the round to […]
OXFORD, United Kingdom – Oxford Nanopore Technologies Ltd., the UK-based developers of nanopore technology for the direct, electronic analysis of single molecules, today announced that it has raised £25 million ($41 million) in new funding via a private placement of ordinary shares in the Company. The funds will support further development, external technology validation and […]
BERWYN, Pa. – AMETEK, Inc. (NYSE: AME) today announced it expects its first quarter results to substantially exceed its prior guidance. The Company now expects first quarter diluted earnings per share to be approximately $0.55 to $0.56, up from its previous guidance of $0.46 to $0.48 per diluted share. First quarter sales are expected to […]
ST. LOUIS and CAMBRIDGE, MASS – Monsanto Company (NYSE: MON) and Atlas Venture, an early-stage venture capital firm based in Cambridge, Mass., today announced an agreement to enter a multi-year collaboration to explore investment opportunities in early-stage life sciences technology companies. Under the agreement, Monsanto will work with Atlas to identify strategic investments in a […]
Gothenburg, Sweden – Cellectricon, a leading provider of screening solutions for drug discovery and cell based assay research, is entering a new expansion phase. The decided share issue will strengthen Cellectricon’s capital base and enable a focused market expansion and value-growth of the product portfolio. The company’s recently launched high throughput systems, Cellaxess®HT and Dynaflow®HT […]
South Easton, MA – Pressure BioSciences, Inc. (NASDAQ: PBIO) (“PBI” or the “Company”) today announced that it has received gross proceeds of $825,720 from the sale of 55,048 units to 10 accredited investors, including the Company’s CEO and President, in the first tranche of the Company’s $6.0 million Series C private placement. Each unit was […]
Microsaic Systems plc, the developer of miniaturised chip-based scientific instruments, is pleased to announce that admission to trading on AIM will become effective, and dealings inthe ordinary shares of the Company will start, at 8.00am today, 11 April 2011, under the ticker symbol “MSYS”. The Admission to AIM follows the Company’s successful fund raising, which […]
San Jose, CA – Bridge Capital Holdings (NASDAQ: BBNK), and its subsidiary Bridge Bank National Association, a full service professional business bank headquartered in Silicon Valley, announced today it has provided Fluidigm Corporation with a $7 million line of credit. The South San Francisco based leader in genomic instruments and microfluidic chips will use this […]
Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells
Madison, WI – Cellular Dynamics International, Inc. (CDI), the world’s only industrial manufacturer of human induced pluripotent stem cells (iPSCs) and tissue cells, has closed on a $30 million private equity round. This recent Series B Preferred Stock financing was led by an entity affiliated with Tactics II Stem Cell Ventures, which along with its […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
